P. Piedbois

发表

Progression-free survival is a surrogate for survival in advanced colorectal cancer.

D. Sargent, M. Buyse, J. Pignon, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Arterial occlusive disease after radiotherapy: a report of fourteen cases.

J. Becquemin, D. Méllière, P. Piedbois, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radio-chimiothérapie adjuvante des cancers du rectum

P. Piedbois, Y. Kirova, L. Feuvret, 1997 .

Progresses in the medical treatment of advanced colorectal cancer.

E. Fabre-Guillevin, P. Piedbois, V. Sultan-Amar, 2005, Roczniki Akademii Medycznej w Bialymstoku.

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.

M. Buyse, O. Bouché, P. Piedbois, 2001, Seminars in oncology.

Should Dukes' B patients receive adjuvant therapy? A statistical perspective.

M. Buyse, P. Piedbois, Marc Buyse, 2001, Seminars in oncology.

What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin?

M. Buyse, P. Piedbois, 1993 .

Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.

J. Tran van Nhieu, I. Sobhani, P. Piedbois, 2007, Archives of surgery.

Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.

J. Bosset, B. Nordlinger, P. Rougier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

V. Sondak, M. Buyse, R. Carlson, 1996, Journal of the National Cancer Institute.

The role of colony stimulating factors in small cell lung cancer: why the question is still unsolved.

M. Buyse, P. Piedbois, V. Trillet-lenoir, 2002, Lung Cancer.

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials

R. Peto, M. Buyse, R. Hills, 2001, The Lancet.

Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.

R. Peto, M. Buyse, R. Gray, 1997, Journal of the National Cancer Institute.

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study.

F. Brunetti, L. Zelek, E. Fabre-Guillevin, 2008, Critical reviews in oncology/hematology.

Meta-analysis: methods, strengths, and weaknesses.

M. Buyse, R. Carlson, P. Piedbois, 2000, Oncology.

Recent meta-analyses in colorectal cancer.

M. Buyse, P. Piedbois, 2000, Current opinion in oncology.

Oral contraceptives may lower the risk of colorectal cancer

P. Piedbois, 2001 .

[Criteria and endpoints in advanced prostate cancer].

M. Buyse, P. Piedbois, 2012, Bulletin du cancer.

Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma.

F. Geara, P. Piedbois, J. Mazeron, 1991, International journal of radiation oncology, biology, physics.

Intrahepatic cholangiocarcinoma. Results of aggressive surgical management.

A. Rahmouni, D. Dhumeaux, P. Piedbois, 1995, Archives of surgery.

Common bile duct stricture as a late complication of upper abdominal radiotherapy.

D. Valla, C. Duvoux, L. Palazzo, 1994, Journal of hepatology.

Induction chemotherapy in head and neck cancer: Results of a phase III trial

P. Piedbois, J. Mazeron, G. Lelièvre, 1992, Head & neck.

Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth.

P. Piedbois, J. Mazeron, G. Marinello, 1990, International journal of radiation oncology, biology, physics.

Meta-analyses of published results are unreliable.

M. Buyse, R. Carlson, P. Piedbois, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France

I. Durand-zaleski, J. Trédaniel, P. Piedbois, 2012, PharmacoEconomics.

Detection and monitoring of serum p 53 antibodies in patients with colorectal cancer

J. Kouyoumdjian, T. Soussi, R. Lubin, 2022 .

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

Geert Molenberghs, Tomasz Burzykowski, Marc Buyse, 2000, The Lancet.

Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.

G. Molenberghs, M. Buyse, R. Carlson, 2001, Journal of the National Cancer Institute.

Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation.

C. Cordonnier, P. Piedbois, V. Benk, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Meta-analyses need time, collaboration, and funding.

M. Buyse, P. Piedbois, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients

M. Buyse, O. Bouché, E. Gamelin, 2005 .

Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma

J. Tran van Nhieu, J. Nhieu, P. Piedbois, 2008, Annals of Surgical Oncology.

Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapy

J. Breau, P. Piedbois, J. Morère, 1987, Cancer.

Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study

D. Dhumeaux, J. Pierga, C. Duvoux, 1994, Cancer.

On the relationship between response to treatment and survival time.

M Buyse, M. Buyse, P. Piedbois, 1996, Statistics in medicine.

Conventional megavoltage radiotherapy in the management of malignant epithelial tumours of the parotid gland.

P. Piedbois, D. Pontvert, F. Brunin, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases.

P. Piedbois, E. Levy, Y. Kirova, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy in the management of epidemic Kaposi's sarcoma.

P. Piedbois, E. Levy, J. Le Bourgeois, 1994, International journal of radiation oncology, biology, physics.

Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals.

C. Le Péchoux, P. Piedbois, J. Le Bourgeois, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Radiotherapy of epidemic Kaposi's sarcoma in patients with AIDS. Analysis of 149 cases treated by extended and/or localized cutaneous irradiation].

A. Taghian, F. Geara, P. Piedbois, 1990, Annales de dermatologie et de venereologie.

Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas.

C. Le Péchoux, P. Piedbois, J. Simon, 1993, International journal of radiation oncology, biology, physics.

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

P. Piedbois, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

FDG PET in patients with cancer of an unknown primary

P. Merlet, A. Syrota, M. Meignan, 2005, Nuclear medicine communications.

Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

J. Kouyoumdjian, T. Soussi, R. Lubin, 1997, Gut.

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.

J. Crook, C. Le Péchoux, P. Piedbois, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue.

J. Crook, P. Piedbois, V. Benk, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

M. Buyse, J. Pignon, P. Rougier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of

E. Van Cutsem, B. Nordlinger, M. Ducreux, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Effectiveness of hemodialysis in a case of acute methotrexate poisoning].

P. Piedbois, E. Gauthier, G. Rostoker, 1990, Presse medicale.

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer

M. Buyse, N. Petrelli, R. Carlson, 1994 .

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation

D. Chopin, K. Leroy, M. Jaurand, 2003, British Journal of Cancer.

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

M. Buyse, J. Pignon, P. Rougier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study.

M. Buyse, P. Hérait, P. Piedbois, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.

M. Buyse, J. Pignon, R. Carlson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis when only the median survival times are known: A comparison with individual patient data results

Stefan Michiels, Pascal Piedbois, Sarah Burdett, 2005, International Journal of Technology Assessment in Health Care.

[Radiotherapy of vertebral hemangioma with neurologic complications].

J. Nguyen, P. Piedbois, J. Mazeron, 1989, Neuro-Chirurgie.

Stage I-II squamous cell carcinoma of the oral cavity treated by iridium-192: is elective neck dissection indicated?

P. Piedbois, A. Coste, J. Mazeron, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.

J. Crook, C. Le Péchoux, P. Piedbois, 1993, Radiotherapy and Oncology.

[Fulvestrant use in clinical practice in France: a pharmacoepidemiologic study].

P. Piedbois, F. Thomas-Delecourt, A. Flinois, 2009, Bulletin du cancer.

Artificial neural networks

Marc Buyse, Pascal Piedbois, M. Buyse, 1997, The Lancet.

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

M. Buyse, O. Bouché, A. de Gramont, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.

M. Buyse, Y. Ohashi, J. Sakamoto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

Marc Buyse, Pascal Piedbois, Thierry Andre, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

M. Buyse, M. Ychou, P. Rougier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

H. Friess, J. Kleeff, W. Scheithauer, 2006, BMC Cancer.

[Arterial stenosis after radiotherapy].

J. Becquemin, P. Piedbois, J. Mazeron, 1990, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

Tumors of the gastrointestinal tract

L. Zelek, D. Khayat, P. Piedbois, 1998 .

Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial).

L. Zelek, M. Buyse, H. Kobeiter, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

M. Buyse, P. Piedbois, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External irradiation prior to conservative surgery for breast cancer treatment.

P. Piedbois, J. Mazeron, Y. Otmezguine, 1991, International journal of radiation oncology, biology, physics.

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

J. Douillard, H. Naman, P. Piedbois, 2007, British Journal of Cancer.

Cancers associés au SIDA.

P. Piedbois, J. L. Bourgeois, H. Frikha, 1995 .

Fluoropyrimidines in Advanced Colorectal Cancer

M. Buyse, P. Piedbois, 2003 .

Contribution of meta-analyses to the evaluation of treatments for advanced colorectal cancer

L. Zelek, M. Buyse, P. Piedbois, 2002, Expert review of anticancer therapy.

Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer.

I. Durand-zaleski, P. Piedbois, A. Bellanger, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer.

V. Sondak, M. Buyse, R. Carlson, 1999, Critical reviews in oncology/hematology.

Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer.

M. Buyse, N. Wolmark, P. Piedbois, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer.

V. Sondak, M. Buyse, R. Carlson, 1997, Journal of the National Cancer Institute.

Comment mesure-t-on le bénéfice net d’un traitement ?

F. Gueyffier, P. Piedbois, J. Bergmann, 2017, Therapie.

How to measure the net benefit of treatment?

F. Gueyffier, P. Piedbois, J. Bergmann, 2017, Therapie.

Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments

M. Buyse, P. Piedbois, 2008, Current opinion in oncology.

Progress in the medical treatment of advanced colorectal cancer

M. Buyse, E. Fabre-Guillevin, P. Piedbois, 2003, Expert review of anticancer therapy.

Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx.

C. Le Péchoux, P. Piedbois, J. Fijuth, 1992, International journal of radiation oncology, biology, physics.

Response to second‐line chemotherapy in patients with metastatic breast carcinoma previously responsive to first‐line treatment

P. Piedbois, B. Brun, M. Benchalal, 1997, Cancer.

Fluoropyrimidines in Advanced Colorectal Cancer: A Review of Six Consecutive Meta-Analyses

M. Buyse, P. Piedbois, 2002 .

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

M. Buyse, A. Piga, C. Köhne, 2001, British Journal of Cancer.

What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin? Advanced Colorectal Meta-analysis Project.

M. Buyse, P. Piedbois, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Bingshu E. Chen, R. Gray, P. Lønning, 2023, The Lancet.

[Comparison of concomitant radiotherapy and chemotherapy with radiotherapy alone in advanced cancers of the head and neck: results of a randomized trial].

P. Piedbois, A. Coste, J. Mazeron, 1996, Bulletin du Cancer/Radiothérapie.

Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials

Tomasz Burzykowski, J. P. Pignon, Kevin Carroll, 2005 .

AERO-B03: A randomized phase II trial of dose-dense docetaxel in node-positive breast cancer

P. Piedbois, M. Fabbro, D. Serin, 2005 .

Surrogate endpoints for overall survival in advanced colorectal cancer: a clinician's perspective

P. Piedbois, Jennifer Miller Croswell, 2008, Statistical methods in medical research.

Adenocarcinomas of unknown primary (ACUP) of the mediastinum mimicking lymphoma: CT findings at diagnosis and follow-up.

A. Luciani, L. Zelek, A. Rahmouni, 2006, European journal of radiology.

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000).

L. Zelek, M. Buyse, P. Piedbois, 2014, European journal of cancer.

Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents

M. Jaurand, Brian Salmons, P. Piedbois, 1998, Oncogene.

[Management of biliary tract carcinomas].

A. Luciani, P. Piedbois, A. Laurent, 2009, La Revue du praticien.

[Prognostic factors of advanced colorectal cancers].

P. Laurent-Puig, P. Piedbois, 1997, La Revue du praticien.

Safety analysis of the French Intergroup R98 trial comparing 5FU-leucovorin alone or with irinotecan in resected stages II-III rectal cancers

M. Ychou, P. Rougier, J. Douillard, 2008 .

Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma

D. Dhumeaux, C. Duvoux, P. Piedbois, 1995, The British journal of surgery.

Adjuvant chemotherapy and radiotherapy in liver transplantation for primary hepatocellular carcinoma: a feasibility study

D. Mathieu, D. Dhumeaux, J. Pierga, 1994 .

Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer

M. Buyse, E. Fabre-Guillevin, P. Piedbois, 2006, Clinical trials.

Response to second‐line chemotherapy in patients with metastatic breast carcinoma previously responsive to first‐line treatment

P. Piedbois, B. Brun, M. Benchalal, 1997, Cancer.

Chemotherapy of nonoperable colorectal liver metastases.

L. Zelek, P. Piedbois, D. Cherqui, 2001, Hepato-gastroenterology.

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

H. Naman, P. Piedbois, J. Delord, 2007, British Journal of Cancer.

L. Zelek, M. Buyse, P. Piedbois, 2014, European journal of cancer.

[Adjuvant chemotherapy of soft tissue sarcoma].

P. Piedbois, E. Levy, P. Thirion, 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Management of breast cancer in the elderly.

P. Piedbois, J. Mazeron, C. Péchoux, 1994, European journal of cancer.